secwatch.observer — SEC 8-K summary
======================================

Issuer:     Privia Health Group, Inc. (PRVA)
CIK:        0001759655
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001759655-26-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Privia Health beats 2025 guidance; revenue $2.12B, net income +59%, Adj. EBITDA $125.5M
--------------------------------------------------------------------------------

- Full-year revenue $2,122.8M, up 22.3% YoY; net income $22.9M, up 59.3% from 2024.
- Adjusted EBITDA $125.5M, +38.8% YoY; net cash from operations $163.4M, +49.5%.
- Year-end cash $479.7M, no debt; all 2025 metrics at or above high end of guidance.
- 2026 guidance: ~20% adjusted EBITDA growth at midpoint, implying ~$150.6M.
- Non-GAAP adjusted EPS $0.99, up 26.9% YoY; GAAP EPS $0.18, up 63.6%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759655/000175965526000007/0001759655-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759655/000175965526000007/prva-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001759655-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer